Visit the WIS FDA Info.com for the best regulatory news and information

Many of our recently held briefings are available on audiocassette and CD. Visit our Archive Library for our highly regarded series on:

  21 CFR Part 11
  Adverse Event
Reporting
  Branded/Generic
Drug Policy
  Clinical Research
  Computer Validation 
  FDA Enforcement
  Human Research Protections
  Prescription Drug Marketing
  Order Form

 
  

 Register Today!

Are Payment Terms Impeding Enrollment Goals From Being Met?
June 26, 2-3pm Eastern

Click here to Register online

Michael Jay, MA, Vice President, RxTrials

Attend this audio conference and learn from this industry expert who is known for his comprehensive understanding of the financial aspects of conducting clinical research.

The majority of sites participate in only one study, and only 25% of sites have been participating in clinical trials for more than five years. This keeps the site side in a constant state of “greenness”. Why is turnover so high? One reason must surely be the slow and late payments from Sponsors/CRO’s, cited as the number one operating concern for research sites in a recent poll.

The speaker will cover:

  • How slow and late payments from sponsors are a research site’s number one operating concern.
  • The average time of a research site’s Accounts Receivable is 120-140 days.
  • Only 16% of Pharmaceutical companies pay early or on time
  • How sites are borrowing against their line of credit more and more to cover the gap between service provided and receipt of sponsor payment
  • IRB reports that they receive a bankruptcy notice from a research site at a rate of one per month.

About the Speaker:
Michael Jay is vice president at RxTrials, Inc. Since joining RxTrials in 2001, he has successfully negotiated and executed hundreds of clinical research contracts. He is recognized in the industry for his comprehensive understanding of the financial aspects of conducting clinical research. He also advises hospitals, private practices and research sites on financial and contractual operational activities. He is frequently invited to speak at national research conferences.

Price

*LIVE audioconference (includes slides, trial subscription and CD of the conference): $399 (after June 21, $450)
*Additional sites per company: $295
*Non-profit/Govt,/Academic: $325
*CD only (includes slides and trial subscription): $325
(Sharing of lines prohibited)

What you will receive:

• Speaker PowerPoint presentation • Free CD recording of the briefing • Free TRIAL subscription to BioResearch Compliance Report • Certificate of attendance (pending completion of evaluation form)

Click here to Register online

Did you miss our recent briefing?

Validation and Use of Excel Spreadsheets in Regulated Environments with
Ludwig Huber, Ph.D, Compliance Program Manager, Agilent Technologies

Click here to Order the CD!

For any questions or concerns please call 703.779.8777

 Do you have an idea for a topic or would you like to be presenter for a future fdainfo.com/expertbriefings/ audioconference? E-mail us.

 

Subscribe!
Enter your e-mail address to get information about upcoming conferences from Expert Briefings!
HTML Text AOL

 

Page last updated June 8, 2007

Washington Information Source © Copyright 2006

208 South King Street, Suite 303, Leesburg, VA 20175
Tel: (703) 779-8777 • Fax: (703) 779-2508
service@fdainfo.com/expertbriefings/
www.fdainfo.com/expertbriefings/